Best Pharma Strategies from the Experts

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

At one point in his career, I Don’t Care Host Kevin Stevenson spent some time on the pharma side of things, in between working at hospitals.

Today he dives back into that world with Donovan Quill, President, and CEO at Optime Care, a nationally recognized pharmacy, distribution, and patient management organization that creates the trusted path to a fulfilled life for patients with rare and orphan disorders.

“What we try to do is create a holistic program for those patients where we combine all the services you would see in a pharmacy in a patient care model,” Quill said. “We try to create a one-stop-shop for patients to really get the care they need from a support standpoint, from affordability, and also to distribute their products to them in their home or site of care.”

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand.” – Donovan Quill

Orphan disorders and drugs are a bit different from regular pharmaceuticals. Typically, an orphan drug is a treatment for a condition with less than 200,000 patients in the U.S., according to the FDA definition. But, what they do at Optime Care is treat disorders that are even more rare, or “Ultra orphan,” according to Quill.

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand,” Quill said. “We really try to focus on the patients who need a little extra care.”

Most of the time, the patients they treat have a disorder they’ve never heard of and are treated with a product they can’t pronounce, Quill said jokingly.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

top 1%
Get Vertical! Going from Idea to the Top 1% in Less Than 3 Years
February 17, 2026

Independent retail is operating in one of the most competitive environments in decades. According to the U.S. Bureau of Labor Statistics, roughly 20% of new businesses fail within their first year, and a whopping 50% don’t make it to year five. At the same time, consumers are increasingly choosing brands that offer community, authenticity,…

Read More
MarTech
How CMOs Must Respond as AI Redefines Marketing and MarTech Strategy
February 16, 2026

AI is shifting marketing from experimentation to operational integration. In this episode, Aby Varma speaks with Palmer Houchins, VP of Marketing at G2, about embedding AI into workflows, rethinking org design, and navigating rapid change across the MarTech landscape. From LLM copilots to agentic workflows, they unpack practical adoption lessons and the increasing importance of…

Read More
experiential learning
Flood the Zone: University of Virginia’s New Strategy to Scale Experiential Learning for Every Student
February 16, 2026

Experiential learning is having a bit of a reckoning moment in higher ed. For years, the default answer was “get an internship” or “do a co-op”—as if every student can pause life, relocate for a summer, and take on a high-stakes role that’s supposed to define their future. But students’ realities have changed: many…

Read More
free tools
The True Cost of Free Tools: When Free Platforms Own More of Your Network Than You Do
February 12, 2026

Nowadays, getting a project off the ground usually means moving fast. A quick map gets sketched. A file gets shared. A design gets reviewed in whatever tool is closest at hand. In the moment, it feels efficient — even smart. But in the telecommunications industry, as networks become more automated, location-aware, and powered by AI,…

Read More